Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Ishida T"" wg kryterium: Autor


Wyświetlanie 1-13 z 13
Tytuł:
Incidental diagnosis of pulmonary cryptococcosis by rebiopsy for epidermal growth factor receptor T790M mutation: A case report.
Autorzy:
Kobe H; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, Okayama, Japan.
Yokoe S; Division of Respiratory Medicine, Department of Internal Medicine Shiga University of Medical Science, Otsu, Japan.
Ishida T; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, Okayama, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Jan; Vol. 14 (2), pp. 210-213. Date of Electronic Publication: 2022 Nov 30.
Typ publikacji:
Case Reports
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/diagnosis
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Antineoplastic Agents*/therapeutic use
Cryptococcosis*/diagnosis
Cryptococcosis*/drug therapy
Cryptococcosis*/genetics
Humans ; ErbB Receptors/therapeutic use ; Drug Resistance, Neoplasm/genetics ; Mutation ; Protein Kinase Inhibitors/therapeutic use ; Biopsy/methods
Raport
Tytuł:
Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study.
Autorzy:
Hosoya K; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Fujimoto D; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan. .; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama City, Wakayama, 641-8509, Japan. .
Morimoto T; Clinical Research Center, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.; Department of Clinical Epidemiology, Hyogo College of Medicine, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan.
Kumagai T; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.
Tamiya A; Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, 1180, Nagasone-cho, Kita-ku, Sakai-shi, Osaka, 591-8555, Japan.
Taniguchi Y; Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, 1180, Nagasone-cho, Kita-ku, Sakai-shi, Osaka, 591-8555, Japan.
Yokoyama T; Department of Respiratory Medicine, Kurashiki Central Hospital, 1-1-1, Miwa, Kurashiki-shi, Okayama, 710-8602, Japan.
Ishida T; Department of Respiratory Medicine, Kurashiki Central Hospital, 1-1-1, Miwa, Kurashiki-shi, Okayama, 710-8602, Japan.
Matsumoto H; Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, 2-17-77, Higashi-Naniwa-Cho, Amagasaki-shi, Hyogo, 660-8550, Japan.
Hirano K; Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, 2-17-77, Higashi-Naniwa-Cho, Amagasaki-shi, Hyogo, 660-8550, Japan.
Kominami R; Department of Respiratory Medicine, Himeji Medical Center, 68, Honmachi, Himeji-shi, Hyogo, 670-8520, Japan.
Tomii K; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Suzuki H; Department of Thoracic Oncology, Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino-shi, Osaka, 583-8588, Japan.
Hirashima T; Department of Thoracic Oncology, Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino-shi, Osaka, 583-8588, Japan.
Tanaka S; Department of Respiratory Medicine, Osaka General Medical Center, 3-1-56, Bandai-Higashi, Sumiyoshi-ku, Osaka-shi, Osaka, 558-8558, Japan.
Uchida J; Department of Respiratory Medicine, Osaka General Medical Center, 3-1-56, Bandai-Higashi, Sumiyoshi-ku, Osaka-shi, Osaka, 558-8558, Japan.
Morita M; Department of Respiratory Medicine, Kobe City Medical Center West Hospital, 2-4, Ichiban-cho, Nagata-ku, Kobe-shi, Hyogo, 653-0013, Japan.
Kanazu M; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, 5-1-1, Toneyama, Toyonaka-shi, Osaka, 560-0045, Japan.
Mori M; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, 5-1-1, Toneyama, Toyonaka-shi, Osaka, 560-0045, Japan.
Nagata K; Department of Respiratory Medicine, Itami City Hospital, 1-100, Koyaike, Itami-shi, Hyogo, 664-8540, Japan.
Fukuda I; Department of Respiratory Medicine, Itami City Hospital, 1-100, Koyaike, Itami-shi, Hyogo, 664-8540, Japan.
Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2021 Apr 01; Vol. 21 (1), pp. 346. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Antibodies, Monoclonal, Humanized/*therapeutic use
Antineoplastic Agents, Immunological/*therapeutic use
B7-H1 Antigen/*metabolism
Carcinoma, Non-Small-Cell Lung/*drug therapy
Lung Neoplasms/*drug therapy
Aged ; Antibodies, Monoclonal, Humanized/pharmacology ; Antineoplastic Agents, Immunological/pharmacology ; Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Humans ; Lung Neoplasms/pathology ; Male ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Prognostic significance of the radiologic features of pneumonitis induced by anti-PD-1 therapy.
Autorzy:
Watanabe S; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Ota T; Niigata Prefectural Shibata Hospital, Niigata, Japan.
Hayashi M; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Ishikawa H; Department of Diagnostic Radiology, Niigata University Medical and Dental Hospital, Niigata, Japan.
Otsubo A; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Shoji S; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Nozaki K; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Ichikawa K; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Kondo R; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Miyabayashi T; Niigata City General Hospital, Niigata, Japan.
Miura S; Niigata Cancer Center Hospital, Niigata, Japan.
Tanaka H; Niigata Cancer Center Hospital, Niigata, Japan.
Abe T; Shinrakuen Hospital, Niigata, Japan.
Okajima M; Saiseikai Niigata Hospital, Niigata, Japan.
Terada M; Saiseikai Niigata Hospital, Niigata, Japan.
Ishida T; Niigata Prefectural Central Hospital, Joetsu, Japan.
Iwashima A; Nagaoka Chuo General Hospital, Nagaoka, Japan.
Sato K; Nagaoka Red Cross Hospital, Nagaoka, Japan.
Yoshizawa H; Niigata Medical Center, Niigata, Japan.
Kikuchi T; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2020 May; Vol. 9 (9), pp. 3070-3077. Date of Electronic Publication: 2020 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents, Immunological/*adverse effects
Carcinoma, Non-Small-Cell Lung/*drug therapy
Lung Neoplasms/*drug therapy
Pneumonia/*pathology
Programmed Cell Death 1 Receptor/*antagonists & inhibitors
Tomography, X-Ray Computed/*methods
Adenocarcinoma of Lung/drug therapy ; Adenocarcinoma of Lung/pathology ; Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Squamous Cell/drug therapy ; Carcinoma, Squamous Cell/pathology ; Female ; Follow-Up Studies ; Humans ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Pneumonia/chemically induced ; Pneumonia/diagnostic imaging ; Prognosis ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł:
Efficacy of EGFR-TKIs with or without upfront brain radiotherapy for EGFR-mutant NSCLC patients with central nervous system metastases.
Autorzy:
Saida Y; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Watanabe S; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Abe T; Department of Respiratory Medicine, Shinrakuen Hospital, Niigata, Japan.
Shoji S; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Nozaki K; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Ichikawa K; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Kondo R; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Koyama K; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.
Miura S; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.
Tanaka H; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.
Okajima M; Department of Respiratory Medicine, Saiseikai Niigata Hospital, Niigata, Japan.
Terada M; Department of Respiratory Medicine, Saiseikai Niigata Hospital, Niigata, Japan.
Ishida T; Department of Respiratory Medicine, Niigata Prefectural Central Hospital, Joetsu, Japan.
Tsukada H; Department of Respiratory Medicine, Niigata City General Hospital, Niigata, Japan.
Makino M; Department of Respiratory Medicine, Shibata Hospital, Shibata, Japan.
Iwashima A; Department of Respiratory Medicine, Nagaoka Chuo General Hospital, Nagaoka, Japan.
Sato K; Department of Respiratory Medicine, Nagaoka Red Cross Hospital, Nagaoka, Japan.
Matsumoto N; Department of Respiratory Medicine, Nishi-Niigata Chuo National Hospital, Niigata, Japan.
Yoshizawa H; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.; Department of Respiratory Medicine, Niigata Medical Center, Niigata, Japan.
Kikuchi T; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2019 Nov; Vol. 10 (11), pp. 2106-2116. Date of Electronic Publication: 2019 Sep 10.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung/*therapy
Central Nervous System Neoplasms/*secondary
Central Nervous System Neoplasms/*therapy
Lung Neoplasms/*therapy
Protein Kinase Inhibitors/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/genetics ; Cranial Irradiation ; ErbB Receptors/genetics ; Female ; Humans ; Lung Neoplasms/genetics ; Male ; Middle Aged ; Mutation ; Prognosis ; Retrospective Studies ; Survival Analysis ; Treatment Failure
Czasopismo naukowe
Tytuł:
Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer.
Autorzy:
Kaneda T; Department of Respiratory Medicine, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Japan.
Yoshioka H; Department of Respiratory Medicine, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Japan. .
Tamiya M; Department of Thoracic Malignancy, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino, Japan.
Tamiya A; Department of Internal Medicine, National Hospital Organization Kinki-chuo Chest Medical Center, Sakai, Japan.
Hata A; Division of Integrated Oncology, Institute of Biomedical Research and Innovation, Kobe, Japan.
Okada A; Department of Respiratory Medicine, Saiseikai Suita Hospital, Suita, Japan.
Niwa T; Department of Respiratory Medicine, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Japan.
Shiroyama T; Department of Thoracic Malignancy, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino, Japan.
Kanazu M; Department of Internal Medicine, National Hospital Organization Kinki-chuo Chest Medical Center, Sakai, Japan.
Ishida T; Department of Respiratory Medicine, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Japan.
Katakami N; Division of Integrated Oncology, Institute of Biomedical Research and Innovation, Kobe, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2018 Jan 02; Vol. 18 (1), pp. 6. Date of Electronic Publication: 2018 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Mutation*
Sequence Deletion*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*pathology
ErbB Receptors/*genetics
Lung Neoplasms/*pathology
Neoplasm Recurrence, Local/*pathology
Adenocarcinoma/drug therapy ; Adenocarcinoma/genetics ; Adenocarcinoma/pathology ; Adult ; Aged ; Biomarkers, Tumor ; Carcinoma, Large Cell/drug therapy ; Carcinoma, Large Cell/genetics ; Carcinoma, Large Cell/pathology ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/genetics ; Cisplatin/administration & dosage ; Female ; Follow-Up Studies ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Male ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/genetics ; Pemetrexed/administration & dosage ; Prognosis ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł:
Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status.
Autorzy:
Ikeda S; Department of Respiratory Medicine, Kurashiki Central Hospital, Miwa 1-1-1, Kurashiki-city, 710-8602, Japan. .; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Tomioka-Higashi 6-16-1, Kanazawa-ku, Yokohama-city, 236-0051, Japan. .
Yoshioka H; Department of Respiratory Medicine, Kurashiki Central Hospital, Miwa 1-1-1, Kurashiki-city, 710-8602, Japan.
Ikeo S; Department of Respiratory Medicine, Kurashiki Central Hospital, Miwa 1-1-1, Kurashiki-city, 710-8602, Japan.
Morita M; Department of Respiratory Medicine, Kurashiki Central Hospital, Miwa 1-1-1, Kurashiki-city, 710-8602, Japan.
Sone N; Department of Respiratory Medicine, Kurashiki Central Hospital, Miwa 1-1-1, Kurashiki-city, 710-8602, Japan.
Niwa T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Tomioka-Higashi 6-16-1, Kanazawa-ku, Yokohama-city, 236-0051, Japan.
Nishiyama A; Department of Respiratory Medicine, Kurashiki Central Hospital, Miwa 1-1-1, Kurashiki-city, 710-8602, Japan.
Yokoyama T; Department of Respiratory Medicine, Kurashiki Central Hospital, Miwa 1-1-1, Kurashiki-city, 710-8602, Japan.
Sekine A; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Tomioka-Higashi 6-16-1, Kanazawa-ku, Yokohama-city, 236-0051, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Tomioka-Higashi 6-16-1, Kanazawa-ku, Yokohama-city, 236-0051, Japan.
Ishida T; Department of Respiratory Medicine, Kurashiki Central Hospital, Miwa 1-1-1, Kurashiki-city, 710-8602, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2017 Nov 28; Vol. 17 (1), pp. 797. Date of Electronic Publication: 2017 Nov 28.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents/*therapeutic use
Biomarkers, Tumor/*metabolism
Carcinoma, Non-Small-Cell Lung/*drug therapy
Lung Neoplasms/*drug therapy
Serum Albumin/*metabolism
Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carboplatin/therapeutic use ; Carcinoma, Non-Small-Cell Lung/metabolism ; Cisplatin/therapeutic use ; Female ; Humans ; Lung Neoplasms/metabolism ; Male ; ROC Curve ; Retrospective Studies ; Survival Analysis ; Tertiary Care Centers ; Treatment Outcome
Czasopismo naukowe
Tytuł:
A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer.
Autorzy:
Minemura H; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. .
Yokouchi H; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. .
Azuma K; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. .
Hirai K; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. .
Sekine S; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. .
Oshima K; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. .
Kanazawa K; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. .
Tanino Y; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. .
Inokoshi Y; Department of Pulmonary Medicine, Saiseikai Fukushima General Hospital, 25 Omori Aza Shimo-harada, Fukushima, 960-1101, Japan. .
Ishii T; Department of Pulmonary Medicine, Saiseikai Fukushima General Hospital, 25 Omori Aza Shimo-harada, Fukushima, 960-1101, Japan. .
Katsuura Y; Department of Pulmonary Medicine, Saiseikai Fukushima General Hospital, 25 Omori Aza Shimo-harada, Fukushima, 960-1101, Japan. .
Oishi A; Department of Thoracic Surgery, Fukushima Red Cross Hospital, 11-31 Irie-cho, Fukushima, 960-8530, Japan. .
Ishida T; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. taku.ishida@nifty.ne.jp.; Clinical Oncology Center, Fukushima Medical University Hospital, 1 Hikariga-oka, Fukushima, 960-1295, Japan. taku.ishida@nifty.ne.jp.
Munakata M; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. .
Pokaż więcej
Źródło:
BMC research notes [BMC Res Notes] 2015 Jun 05; Vol. 8, pp. 220. Date of Electronic Publication: 2015 Jun 05.
Typ publikacji:
Clinical Trial, Phase II; Journal Article
MeSH Terms:
Antineoplastic Agents/*administration & dosage
Carcinoma, Non-Small-Cell Lung/*drug therapy
ErbB Receptors/*antagonists & inhibitors
Erlotinib Hydrochloride/*administration & dosage
Lung Neoplasms/*drug therapy
Protein Kinase Inhibitors/*administration & dosage
Administration, Oral ; Age Factors ; Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Carcinoma, Non-Small-Cell Lung/enzymology ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Disease Progression ; Disease-Free Survival ; Drug Administration Schedule ; Early Termination of Clinical Trials ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Erlotinib Hydrochloride/adverse effects ; Female ; Humans ; Japan ; Lung Neoplasms/enzymology ; Lung Neoplasms/genetics ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Neoplasm Staging ; Prospective Studies ; Protein Kinase Inhibitors/adverse effects ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Successful treatment of unresectable advanced hepatoblastoma: living liver transplantation after surgical removal of lung metastasis.
Autorzy:
Miyamura T; Department of Pediatrics, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan. />Yoshida R
Yagi T
Matsukawa H
Chayama K
Ishida T
Washio K
Morishita N
Oda M
Morishima T
Pokaż więcej
Źródło:
Pediatric transplantation [Pediatr Transplant] 2011 Aug; Vol. 15 (5), pp. E87-91. Date of Electronic Publication: 2010 Jan 11.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hepatoblastoma/*surgery
Hepatoblastoma/*therapy
Liver Neoplasms/*surgery
Liver Neoplasms/*therapy
Liver Transplantation/*methods
Lung Neoplasms/*pathology
Lung Neoplasms/*surgery
Child, Preschool ; Hepatic Veins/pathology ; Humans ; Living Donors ; Lung Neoplasms/complications ; Male ; Neoplasm Metastasis ; Prognosis ; Tomography, X-Ray Computed/methods ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Primary pulmonary synovial sarcoma - transbronchial needle aspiration is a diagnostic approach: a case report with cytological features.
Autorzy:
Kusakabe T; Department of Pathology, School of Medicine, Fukushima Medical University, Fukushima, Japan. />Watanabe K
Nomura-Tanaka M
Ishida T
Munakata M
Suzuki T
Pokaż więcej
Źródło:
Cytopathology : official journal of the British Society for Clinical Cytology [Cytopathology] 2010 Feb; Vol. 21 (1), pp. 52-5. Date of Electronic Publication: 2008 Jul 09.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lung Neoplasms/*pathology
Sarcoma, Synovial/*pathology
Aged ; Biomarkers, Tumor/analysis ; Biopsy, Fine-Needle/methods ; Bronchoscopy ; Humans ; Immunoenzyme Techniques ; Lung Neoplasms/chemistry ; Lung Neoplasms/surgery ; Male ; Mucin-1/analysis ; Oncogene Proteins, Fusion/metabolism ; Sarcoma, Synovial/chemistry ; Sarcoma, Synovial/surgery ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł:
EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers.
Autorzy:
Fukuyoshi Y; Department of Surgery, Medical Institute of Bioregulation, Kyushu University, 4546 Tsurumihara, Beppu 874-0838, Japan.
Inoue H
Kita Y
Utsunomiya T
Ishida T
Mori M
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2008 May 06; Vol. 98 (9), pp. 1536-9. Date of Electronic Publication: 2008 Apr 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor/*analysis
Breast Neoplasms/*chemistry
Carcinoma, Non-Small-Cell Lung/*chemistry
Gastrointestinal Neoplasms/*chemistry
Lung Neoplasms/*chemistry
Oncogene Proteins, Fusion/*analysis
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Reverse Transcriptase Polymerase Chain Reaction
Czasopismo naukowe
Tytuł:
Pulmonary blastoma in an adult. A case with rapid progression.
Autorzy:
Ondo K; Department of Surgery, Hiroshima Red Cross Hospital, Japan.
Ishida T
Yamazaki K
Ishii T
Yamamoto K
Odashiro T
Saito G
Kido A
Sasaki Y
Yukaya H
Fujiwara M
Sugio K
Pokaż więcej
Źródło:
Scandinavian cardiovascular journal : SCJ [Scand Cardiovasc J] 1998; Vol. 32 (4), pp. 247-9.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lung Neoplasms/*diagnosis
Pulmonary Blastoma/*diagnosis
Combined Modality Therapy ; Disease Progression ; Fatal Outcome ; Humans ; Lung Neoplasms/pathology ; Lung Neoplasms/therapy ; Male ; Middle Aged ; Pulmonary Blastoma/pathology ; Pulmonary Blastoma/therapy ; Tomography, X-Ray Computed
Czasopismo naukowe
    Wyświetlanie 1-13 z 13

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies